Table 4.
Associations between other patient factors and hypertension control
| Variable | Controlled BP | |||
|---|---|---|---|---|
| No | Yes | χ2 | p-value | |
| n(%) | n(%) | |||
| Comorbidity | ||||
| No | 59(62.11) | 36(37.89) | 15.2969 | < 0.001 |
| Yes | 217(81.89) | 48(18.11) | ||
| Diabetes | ||||
| No | 147(74.62) | 50(25.38) | 1.0195 | 0.313 |
| Yes | 129(79.14) | 34(20.86) | ||
| CKD | ||||
| No | 262(75.72) | 84(24.28) | 0.047c | |
| Yes | 14(100.00) | 0(0.00) | ||
| Dyslipidaemia | ||||
| No | 225(74.01) | 79(25.99) | 7.6921 | 0.006 |
| Yes | 51(91.07) | 5(8.93) | ||
| Stroke | ||||
| No | 262(76.83) | 79(23.17) | 0.0997 | 0.752 |
| Yes | 14(73.68) | 5(26.32) | ||
| Pills taken for comorbidity | ||||
| 1–2 | 84(80.77) | 20(19.23) | 0.725c | |
| 3–6 | 130(83.87) | 25(16.13) | ||
| 7–13 | 3(75.00) | 1(25.00) | ||
| Non-Prescribed Medb. | ||||
| No | 209(76.56) | 64(23.44) | 0.0076 | 0.930 |
| Yes | 67(77.67) | 20(22.99) | ||
| Length of diagnosis | ||||
| 1 | 21(63.64) | 12(36.36) | 11.9293 | 0.008 |
| 2–5 | 112(84.21) | 21(15.36) | ||
| 6–10 | 91(78.45) | 25(21.55) | ||
| 21–40 | 52(66.67) | 26(33.33) | ||
| No. BP pills taken per day | ||||
| 1–2 | 85(64.89) | 46(35.11) | 15.978 | < 0.001 |
| 2–4 | 191(83.41) | 38(16.59) | ||
| Total | 276 (76.67) | 84 (23.33) | ||
n: Frequencies,%:row percentages
a Co-morbidity was defined as the presence of diabetes, chronic kidney disease or dyslipidaemia
bNon-prescribed medication refers to any drug the patient is currently taking that is not prescribed by the attending physician
c Fishers’ exact value